Literature DB >> 27879537

Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women.

Anthony N Audino1, Bhuvana A Setty, Nicholas D Yeager.   

Abstract

Soft tissue sarcoma constitutes 8% of all tumors in adolescent and young adults (AYA), with rhabdomyosarcoma (RMS) accounting for 5.2% to 6.5% of the soft tissue sarcoma total within this group. AYAs have a higher propensity for metastasis and inferior outcomes. Metastases to the breast have been reported in ∼3% to 6% of RMS cases. A review of our hospital's tumor registry identified cases of RMS diagnosed between January 1, 2004 and December 31, 2013. A total of 46 patients with RMS were identified, having a mean age of 12.5 years (range, 1 to 49 y). There were 26 males (57%) and 20 females (43%). Eighteen patients (39%) were AYAs, including 10 women. Four patients (8.7%) were identified with breast involvement, all of whom were AYA females. Treatment modalities included chemotherapy, surgical resection, and radiation. One patient is a long-term survivor. Although RMS is uncommon in AYAs, breast involvement occurs almost exclusively in AYA women and is associated with alveolar histology, metastatic disease, and poor outcomes. In total, 4/10 of all AYA females had breast involvement. Routine examination or imaging of the breasts in AYAs with RMS is not currently standard practice at diagnosis or follow-up, but this analysis suggests it should be considered in female AYA patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27879537     DOI: 10.1097/MPH.0000000000000710

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Rhabdomyosarcoma of the breast: Report of a rare malignancy.

Authors:  Yufen Yuan; Junna Hou; Yunbao Pan
Journal:  Cancer Biol Ther       Date:  2017-09-02       Impact factor: 4.742

2.  Primary Rhabdomyosarcoma of the Breast: Study of Three Cases at One Institution with a Review of Primary Breast Sarcomas.

Authors:  Junyoung Shin; Hee Jeong Kim; Dae-Yeon Kim; Gyungyub Gong; Kyung-Ja Cho
Journal:  J Pathol Transl Med       Date:  2019-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.